Acumen Pharmaceuticals Reports Q3 Income From Operations
Acumen Pharmaceuticals reported Q3 income from operations, compared with an IBES estimate of USD -30.7 million.
Story updates
11:09:29 AM UTC
SquawkNews
Oct 26 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 operating expenses USD 25.813 million.